Pharmaceutical Intermediates Market Scope and Growth BURLINGAME, CA, UNITED STATES, March 13, 2025 /EINPresswire / -- The pharmaceutical inter ...
The salicylic acid market was valued at $431.7 million in 2020, and is projected to reach $886.9 million by 2030, growing at a CAGR of 7.5% from 2020 ...
The report warns that big pharma companies can't rest on their laurels ... Source: IMS Health World Reviews and MIDAS, December 2014. World Review 2005 & 2010. *Actavis/Allergan shown by putting ...
Using MIDAS sales data, we compared the performances ... healthcare systems and pharmaceutical companies see alignment. For pharma, the first step is to understand the changed patient journey ...
On Tuesday, India’s top specialty generics company Sun Pharma announced the acquisition of the US-based Checkpoint for $355 million to enhance its oncology portfolio. Analysts view this ...
Salicylic Acid Market Poised for Significant Growth, Estimated to Reach USD 1,015.33 Million by 2035
The global salicylic acid market is projected to witness substantial growth, with its valuation anticipated to reach USD 1,015.33 million by 2035, growing at a CAGR of 7.1% from 2025 to 2035. This ...
MIDAS EXTRA SHARE TIPS: Online printing firm looks good on paper, as it's good with paper This software developer's foray into the wearable device market could prove fruitful if take-up from ...
Gold's bullish momentum resumes, with prices surging past corrections and targets above $3,000. Check out more here.
MIDAS EXTRA SHARE TIPS: Online printing firm looks good on paper, as it's good with paper MIDAS EXTRA SHARE TIPS: Software firm's plans are 'fit' for risky investors This recently-floated US-based ...
Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial ...
Rare mineral found primarily in Saskatchewan, home to the world's largest mines and deposits You can save this article by registering for free here. Or sign-in if you have an account. Anyone ...
He was referring to the concentration of U.S. pharmaceutical companies in Ireland, due to the country’s tax policies. “We had stupid leaders. We had leaders that didn’t have a clue or let ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results